Literature DB >> 22514372

Pharmacodynamics and alternative antimicrobial dosing regimens.

J Conly1, S Shafran.   

Abstract

Year:  1995        PMID： 22514372      PMCID： PMC3327905          DOI： 10.1155/1995/657126

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  26 in total

1.  Once-daily aminoglycosides.

Authors:  D Nicolau; R Quintiliani; C H Nightingale
Journal:  Conn Med       Date:  1992-10

2.  The Treatment of Lobar Pneumonia and Pneumococcal Empyema with Penicillin.

Authors:  W S Tillett; M J Cambier; J E McCormack
Journal:  Bull N Y Acad Med       Date:  1944-03

3.  Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.

Authors:  J Blaser; B B Stone; M C Groner; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

4.  The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

Authors:  R D Moore; C R Smith; P S Lietman
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

5.  Antibiotics and human defence mechanisms: the effects of ampicillin and cefotaxime on intra- and extracellular killing of Salmonella enteritidis.

Authors:  M H Long; C E Shapland; L A Leonard; H Rowland
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

Review 6.  Killing and regrowth of bacteria in vitro: a review.

Authors:  W A Craig; S C Ebert
Journal:  Scand J Infect Dis Suppl       Date:  1990

7.  Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.

Authors: 
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

8.  Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice.

Authors:  A U Gerber; W A Craig; H P Brugger; C Feller; A P Vastola; J Brandel
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

9.  Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.

Authors:  A U Gerber; A P Vastola; J Brandel; W A Craig
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

10.  Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.

Authors:  D Paradis; F Vallée; S Allard; C Bisson; N Daviau; C Drapeau; F Auger; M LeBel
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.